Siemens Fonds Invest Gmb H Incyte Corp Transaction History

Siemens Fonds Invest Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $912 - $1,118	-13 Reduced 0.18%	7,160 $517,000
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $17,265 - $21,616	-257 Reduced 3.46%	7,173 $576,000
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $37,433 - $43,799	591 Added 8.64%	7,430 $551,000
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $469,634 - $574,612	6,839 New	6,839 $470,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Siemens Fonds Invest Gmb H, based on Form 13F filings with the SEC.

Stay updated on Siemens Fonds Invest Gmb H with notifications on news.